Patents and the faster introduction of new drugs in developing countries

Applied Economics Letters

Volumn 12, Issue 6, 2005, Pages 379-382

  Borrell, Joan Ramon ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DEVELOPING WORLD; DRUG PRESCRIBING; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 19844379455     PISSN: 13504851     EISSN: None     Source Type: Journal    
DOI: 10.1080/13504850500042744     Document Type: Article

References (8)

1. Balasubramaniam, T. (2000) Background Information on Fourteen FDA Approved HIV/AIDS Drugs, Consumer Project on Technology. Published online: http://www.cptech.org/, version 1.41, June 8.
2. Borrell, J. R. (2004) Pricing and patents of HIV/AIDS drugs in developing countries, mimeo.
3. Bresnahan, T. F. and Reiss, P. C. (1987) Do entry conditions vary across markets? Brookings Papers on Economic Activity, 3, 833-71.
4. Bresnahan, T. F. and Reis, P. C. (1990) Entry in monopoly markets, The Review of Economic Studies, 57(4), 531-53.
5. Bresnahan, T. F. and Reiss, P. C. (1991a) Empirical models of discrete games, Journal of Econometrics, 48(1-2), 57-81.
6. Bresnahan, T. F. and Reiss, P. C. (1991b) Entry and competition in concentrated markets, Journal of Political Economy, 99(51), 977-1009.
7. FDA (2000) Electronic Orange Book. Approved Drug Products with Therapeutic Evaluations, US Department of Health and Human Services, Federal Drug Administration, Rockville, (MD, USA). Published online: http://www.fda.gov/cder/ob.
8. PDR (2000) Physicians' Desk Reference: PDR, 54th edn, Medical Economics, Oradell, NJ, USA.